<DOC>
	<DOCNO>NCT02545439</DOCNO>
	<brief_summary>This study evaluate impact CYP3A4 induction single-dose pharmacokinetics ALKS 5461 .</brief_summary>
	<brief_title>A Drug-drug Interaction Study ALKS 5461 Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Has body mass index ( BMI ) 18.0 30.0 kg/m^2 Is good physical health Agrees use approve method contraception duration study Additional criterion may apply Is currently pregnant breastfeeding Has lifetime history substance abuse disorder Has use nicotine within 90 day prior study anticipates need use nicotine study period Has use prescription overthecounter medication , include natural health product dietary supplement ( exception prescription contraceptives hormonal replacement , acetaminophen , ibuprofen , multivitamin ) within 14 day prior study start Has use opioids within 30 day prior screen , anticipated need opioid medication point study Has use alcohol within 72 hour prior inpatient period Is heavy caffeine drinker ( regularly consume 5 caffeinated beverage per day ) Has history intolerance hypersensitivity opioids ( buprenorphine ) opioid antagonist ( naltrexone , naloxone ) Additional criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Alkermes</keyword>
	<keyword>Samidorphan</keyword>
	<keyword>ALKS 5461</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>